Фармацевтика
Study in rats finds long-term omeprazole use disrupts mineral levels linked to anemia and bone health risks
Сообщено ИИ Изображение, созданное ИИ Проверено фактами
Researchers in Brazil report that prolonged use of the proton pump inhibitor (PPI) omeprazole altered iron and calcium measures in adult rats and shifted how several minerals were distributed across organs—changes they say are consistent with higher risks of anemia and possible bone health harms. The authors and Brazil’s health regulator stress that PPIs remain effective for acid-related disorders, but warn against extended, unsupervised use.
Egypt's Prime Minister Mostafa Madbouly chaired a high-level meeting on Sunday to review the availability of pharmaceutical products and active raw materials in the domestic market. The session, attended by ministers and officials, emphasized ensuring adequate strategic drug reserves and monitoring supply chains while advancing localization efforts. A detailed report confirmed sufficient inventories to meet local demand.
Сообщено ИИ
Collegium Pharmaceutical, Inc. (COLL) held an investor conference call on March 19, 2026, to discuss its acquisition of AZSTARYS and relevant corporate subsidiaries from Corium Therapeutics. The deal aims to expand the company's position in the ADHD market. Executives including CEO Vikram Karnani joined the call.
Amarin Corporation plc has released a slide deck accompanying its Q4 2025 earnings call. The presentation was published on February 25, 2026, via Seeking Alpha.
Сообщено ИИ
Alkermes plc has published a slide deck accompanying its 2025 fourth-quarter earnings call. The materials were made available on February 25, 2026. This release provides insights into the company's financial performance for the period.
A Delhi High Court verdict on January 12 has allowed Indian pharma company Zydus Lifesciences to manufacture and sell a biosimilar version of Bristol Myers-Squibb's cancer drug Nivolumab. This ruling could pave the way for more affordable immunotherapy treatments for cancer patients in India. Nivolumab is effective against various cancers, with its patent set to expire in May 2026.
Сообщено ИИ
Egypt's Minister of Health and Population Khaled Abdel Ghaffar met Kazakhstan's ambassador to Egypt, Askar Zhenis, to discuss strengthening bilateral cooperation in healthcare and pharmaceutical manufacturing technology. Abdel Ghaffar emphasized Egypt's interest in expanding ties through the transfer of pharmaceutical manufacturing technologies and harmonizing Good Manufacturing Practice standards. The talks covered collaboration in pharmaceutical production, biotechnology, and public health initiatives.
Relmada Therapeutics holds Q4 2025 earnings conference call
17 марта 2026, 05:02Egypt steps up research cooperation with Takeda
10 марта 2026, 18:13Roche shares decline after giredestrant trial fails endpoint
05 марта 2026, 02:11Clara Foods develops world's first animal-free pepsin
02 марта 2026, 08:51Egypt unveils integrated plan to boost pharmaceutical and garments exports
25 февраля 2026, 06:06Sarepta Therapeutics holds Q4 2025 earnings call
17 февраля 2026, 01:32Farmacias similares begins expansion to japan
14 февраля 2026, 10:20Egypt offers WHO-certified expertise to boost Africa's medicine production
05 февраля 2026, 16:06Japanese drugmakers slump after Trump unveils discount drug website
30 января 2026, 21:57Australian sepsis drug advances in human trial